UBS AM’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-857
| Closed | -$294K | – | 2681 |
|
|
2022
Q4 | $294K | Hold |
857
| – | – | ﹤0.01% | 2335 |
|
|
2022
Q3 | $162K | Hold |
857
| – | – | ﹤0.01% | 2641 |
|
|
2022
Q2 | $181K | Hold |
857
| – | – | ﹤0.01% | 2594 |
|
|
2022
Q1 | $287K | Hold |
857
| – | – | ﹤0.01% | 2609 |
|
|
2021
Q4 | $279K | Sell |
857
-488
| -36% | -$159K | ﹤0.01% | 2698 |
|
|
2021
Q3 | $653K | Buy |
1,345
+57
| +4% | +$27.7K | ﹤0.01% | 2379 |
|
|
2021
Q2 | $599K | Buy |
1,288
+250
| +24% | +$116K | ﹤0.01% | 2460 |
|
|
2021
Q1 | $716K | Buy |
1,038
+225
| +28% | +$155K | ﹤0.01% | 2241 |
|
|
2020
Q4 | $601K | Sell |
813
-100
| -11% | -$73.9K | ﹤0.01% | 2227 |
|
|
2020
Q3 | $633K | Buy |
913
+582
| +176% | +$404K | ﹤0.01% | 2027 |
|
|
2020
Q2 | $281K | Buy |
+331
| New | +$281K | ﹤0.01% | 2298 |
|